McEnery M W, Snowman A M, Trifiletti R R, Snyder S H
Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2185.
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3170-4. doi: 10.1073/pnas.89.8.3170.
The mitochondrial benzodiazepine receptor (mBzR) has been solubilized with retention of reversible ligand binding, and the associated subunits were characterized. mBzR comprises immunologically distinct protein subunits of 18-, 30-, and 32-kDa. The 18-kDa protein is labeled by the isoquinoline carboxamide mBzR ligand [3H]PK14105, whereas the 30- and 32-kDa subunits are labeled by the benzodiazepine (Bz) ligands [3H]flunitrazepam and [3H]AHN-086. Selective antibodies and reagents identify the 32- and 30-kDa proteins as the voltage-dependent anion channel (VDAC) and the adenine nucleotide carrier (ADC), respectively. While isoquinoline carboxamide and Bz ligands target different subunits, they interact allosterically, as the binding of Bz and isoquinoline carboxamide ligands is mutually competitive at low nanomolar concentrations. Moreover, eosin-5-maleimide and mercuric chloride inhibit [3H]PK11195 binding to the intact receptor via sulfhydryl groups that are present in ADC. VDAC and ADC, outer and inner mitochondrial membrane channel proteins, respectively, together with the 18-kDa subunit, may comprise mBzR at functionally important transport sites at the junction of two mitochondrial membranes.
线粒体苯二氮䓬受体(mBzR)已被增溶,并保留了可逆配体结合能力,同时对相关亚基进行了表征。mBzR由18 kDa、30 kDa和32 kDa免疫特性不同的蛋白质亚基组成。18 kDa的蛋白质被异喹啉甲酰胺mBzR配体[3H]PK14105标记,而30 kDa和32 kDa的亚基则被苯二氮䓬(Bz)配体[3H]氟硝西泮和[3H]AHN - 086标记。选择性抗体和试剂分别将32 kDa和30 kDa的蛋白质鉴定为电压依赖性阴离子通道(VDAC)和腺嘌呤核苷酸载体(ADC)。虽然异喹啉甲酰胺和Bz配体靶向不同的亚基,但它们会发生变构相互作用,因为在低纳摩尔浓度下,Bz和异喹啉甲酰胺配体的结合相互竞争。此外, eosin - 5 - 马来酰亚胺和氯化汞通过ADC中存在的巯基抑制[3H]PK11195与完整受体的结合。VDAC和ADC分别是线粒体外膜和内膜通道蛋白,它们与18 kDa亚基一起,可能在两个线粒体膜交界处的功能重要转运位点构成mBzR。